Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis
Chiang, L.Y.; Ejzykowicz, D.E.; Tian, Z.-Q.; Katz, L.; Filler, S.G.
Antimicrobial Agents and ChemoTherapy 50(10): 3464-3466
2006
ISSN/ISBN: 0066-4804 PMID: 17005833 DOI: 10.1128/aac.00558-06
Accession: 012784971
Ambruticins are a family of polyketides. The antifungal activity of an ambruticin, KOSN-2079, was tested in the mouse model of invasive aspergillosis. KOSN-2079 significantly reduced pulmonary fungal burdens and improved survival over that with the vehicle control. These results support the continued development of ambruticins as antifungal agents.
Full Text Article emailed within 0-6 h: $19.90
Related References
Shubitz, L.F.; Galgiani, J.N.; Tian, Z.-Q.; Zhong, Z.; Timmermans, P.; Katz, L. 2006: Efficacy of ambruticin analogs in a murine model of coccidioidomycosis Antimicrobial Agents and ChemoTherapy 50(10): 3467-3469Lewis, R.E.; Prince, R.A.; Chi, J.; Kontoyiannis, D.P. 2002: Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis Antimicrobial Agents and Chemotherapy 46(10): 3208-3214
Lewis, R.E.; Albert, N.D.; Kontoyiannis, D.P. 2008: Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 52(11): 4178-4180
Natesan, S.K.; L. Cutright, J. 2019: In vivo Efficacy of Posaconazole (POS) against Voriconazole Resistant (VCZ-R) Aspergillus flavus in an Inhalational Neutropenic Murine Model of Invasive Pulmonary Aspergillosis Microbiology Research Journal International: 1-7
Sakita, K.M.; Capoci, I.R.G.; Conrado, P.C.V.; Rodrigues-Vendramini, F.A.V.; Faria, D.R.; Arita, G.S.; Becker, T.ân.C.A.; Bonfim-Mendonça, P.d.S.; Svidzinski, T.I.E.; Kioshima, E.S. 2021: Efficacy of Ebselen Against Invasive Aspergillosis in a Murine Model Frontiers in Cellular and Infection Microbiology 11: 684525
Sheppard, D.C.; Rieg, G.; Chiang, L.Y.; Filler, S.G.; Edwards, J.E.; Ibrahim, A.S. 2004: Novel inhalational murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 48(5): 1908-1911
Sheppard, D.C.; Graybill, J.R.; Najvar, L.K.; Chiang, L.Y.; Doedt, T.; Kirkpatrick, W.R.; Bocanegra, R.; Vallor, A.C.; Patterson, T.F.; Filler, S.G. 2006: Standardization of an experimental murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 50(10): 3501-3503
Ibrahim, A.S.; Gebremariam, T.; French, S.W.; Edwards, J.E.; Spellberg, B. 2010: The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis Journal of Antimicrobial ChemoTherapy 65(2): 289-292
Szigeti, Z.M.; Talas, L.; Palicz, Z.; Szentesi, P.; Hargitai, Z.; Csernoch, L.; Balla, J.; Pocsi, I.; Banfalvi, G.; Szeman-Nagy, G. 2018: Murine model to follow hyphal development in invasive pulmonary aspergillosis Applied Microbiology and Biotechnology 102(6): 2817-2825
Clemons, K.V.; Schwartz, J.A.; Stevens, D.A. 2011: Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis Medical Mycology 49(8): 834-847
Te Dorsthorst, D.T.A.; Verweij, P.E.; Meis, J.F.G.M.; Mouton, J.W. 2005: Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis Antimicrobial Agents and ChemoTherapy 49(10): 4220-4226
Grahl, N.; Kowalski, C.H.; Cramer, R.A. 2021: Detection of Low Oxygen Microenvironments in a Murine Model of Invasive Pulmonary Aspergillosis Using Pimonidazole Methods in Molecular Biology 2260: 197-205
Dabur, R.; Diwedi, S.K.; Yadav, V.; Mishra, V.; Singh, R.; Singh, H.; Sharma, G.L. 2005: Efficacy of 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrole-2-yl)-1-methylethyl pentanoate in a murine model of invasive aspergillosis Antimicrobial Agents and ChemoTherapy 49(10): 4365-4367
Kirkpatrick, W.R.; Najvar, L.K.; Vallor, A.C.; Wiederhold, N.P.; Bocanegra, R.; Pfeiffer, J.; Perkins, K.; Kugler, A.R.; Sweeney, T.D.; Patterson, T.F. 2012: Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis Journal of Antimicrobial ChemoTherapy 67(4): 970-976
Chandrasekar, P.H.; Cutright, J.; Manavathu, E. 2000: Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model Journal of Antimicrobial ChemoTherapy 45(5): 673-676
Takazono, T.; Izumikawa, K.; Mihara, T.; Kosai, K.; Saijo, T.; Imamura, Y.; Miyazaki, T.; Seki, M.; Kakeya, H.; Yamamoto, Y.; Yanagihara, K.; Kohno, S. 2009: Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 53(8): 3508-3510
Kaur, S.; Gupta, V.K.; Thiel, S.; Sarma, P.U.; Madan, T. 2007: Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis Clinical and Experimental Immunology 148(2): 382-389
Madan, T.; Kishore, U.; Singh, M.; Strong, P.; Hussain, E.M.; Reid, K.B.; Sarma, P.U. 2001: Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis Infection and Immunity 69(4): 2728-2731
Bhattacharya, S.; Amarsaikhan, N.; Maupin, A.J.; Schlosser, A.; Füchtbauer, E.-M.; Holmskov, U.; Moeller, J.B.; Templeton, S.P. 2021: FIBCD1 Deficiency Decreases Disease Severity in a Murine Model of Invasive Pulmonary Aspergillosis Immunohorizons 5(12): 983-993
Nawada, R.; Amitani, R.; Tanaka, E.; Niimi, A.; Suzuki, K.; Murayama, T.; Kuze, F. 1996: Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection Journal of Clinical Microbiology 34(6): 1433-1439